CYP 6.12% 26.0¢ cynata therapeutics limited

Ann: Investor Presentation, page-563

  1. 4,027 Posts.
    lightbulb Created with Sketch. 295
    Your infatuation with the next possible MSC therapy providing Company is inspiring for all holders of MSB. Your lack of providing and disputing what the alarming side affects of iPSC's has is also alarming.

    One will be passed or passed over again, no matter what you say, and the other being CYP that you hold, perhaps will never even make it to accepted application.

    But you keep ranting on this CYP forum about MSB and I will keep ranting on this forum about CYP and the dangers of iPSC therapy as it appears in very easy to access research.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.